Treatment outcome of docetaxel plus prednisolone for metastatic castration-resistant prostate cancer...
Treatment outcome of docetaxel plus prednisolone for metastatic castration-resistant prostate cancer in Korea
About this item
Full title
Author / Creator
Publisher
India: Medknow Publications and Media Pvt. Ltd
Journal title
Language
English
Formats
Publication information
Publisher
India: Medknow Publications and Media Pvt. Ltd
Subjects
More information
Scope and Contents
Contents
We retrospectively reviewed the treatment outcomes of docetaxel plus prednisolone chemotherapy in Korean men with metastatic castration-resistant prostate cancer (mCRPC).
This Study included 106 consecutive Korean patients with mCRPC who were treated with a 3-weekly regimen of docetaxel plus prednisolone chemotherapy between 2005 and 2011. The o...
Alternative Titles
Full title
Treatment outcome of docetaxel plus prednisolone for metastatic castration-resistant prostate cancer in Korea
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_1545416868
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1545416868
Other Identifiers
ISSN
0973-1482
E-ISSN
1998-4138
DOI
10.4103/0973-1482.136546
